BRIEF published on 07/09/2024 at 12:35, 1 year 9 months ago Immunic nomme Jason Tardio au poste de directeur de l'exploitation et président Sclérose En Plaques Vidofludimus Calcium Nomination Du COO Immunitaire Jason Tardio
PRESS RELEASE published on 07/09/2024 at 12:30, 1 year 9 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 1 year 10 months ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
BRIEF published on 05/28/2024 at 12:35, 1 year 10 months ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
PRESS RELEASE published on 05/28/2024 at 12:30, 1 year 10 months ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 1 year 11 months ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 1 year 11 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 11 months ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF published on 05/06/2024 at 12:35, 1 year 11 months ago Immunic AG Announces Participation in May Conferences for Investor and Scientific Communities Investor Conferences Clinical Trials Immunic AG Scientific Conferences Autoimmune Disease Treatments
BRIEF published on 05/06/2024 at 12:35, 1 year 11 months ago Immunic AG annonce sa participation aux conférences de mai destinées aux communautés d'investisseurs et scientifiques Essais Cliniques Conférences Investisseurs Immunic SA Conférences Scientifiques Traitements Des Maladies Auto-immunes
Published on 04/21/2026 at 17:40, 1 hour 18 minutes ago Karbon-X Reports $60.8 Million in Nine-Month Revenue and Files Q3 Form 10-Q
Published on 04/21/2026 at 15:00, 3 hours 58 minutes ago Route1 Announces Launch Of "Mr. Parking" And Provides Update On Upcoming Financial Reporting
Published on 04/21/2026 at 14:30, 4 hours 28 minutes ago Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides
Published on 04/21/2026 at 18:40, 17 minutes ago First Release of Michter's US★1 Barrel Strength Sour Mash Kentucky Whiskey
Published on 04/21/2026 at 18:00, 57 minutes ago EuroTeleSites Makes a Successful Start to the Year and Meets Expectations in the First Quarter
Published on 04/21/2026 at 18:00, 57 minutes ago BOA CONCEPT Group : Fort dynamisme commercial de BOA Concept Group
Published on 04/21/2026 at 18:00, 57 minutes ago ALTHEORA: RESULTATS ANNUELS 2025 - Amélioration de la performance industrielle
Published on 04/21/2026 at 18:00, 58 minutes ago Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 18:00, 58 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mars 2026
Published on 04/21/2026 at 17:40, 1 hour 17 minutes ago AGM of May 12, 2026 : Formalities for obtaining the documents in preparation of the Annual General Meeting
